Sun Pharma Advanced Research Company informs about press release

17 Dec 2024 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed the Press Release titled ‘SPARC Announces Signing of Binding Letter of Intent with UCSF and Tiller Therapeutics for Pre-clinical Oncology Asset and Associated Intellectual Property’, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

134.05 -1.55 (-1.14%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 520.25
CMS Info Systems 344.60
Sagility 52.62
Smartworks Coworking 468.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×